Evidence map›Paper›PMID 27194476›Full record

ReviewNature reviews. Neuroscience2016

Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Jerome Mertens, Maria C Marchetto, Cedric Bardy, Fred H Gage

Abstract readReview
In one paragraph

Review in Nature reviews. Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 176 papers.

0numbers the graph read from it
0cells of the map it votes in
176citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

176 citing papers in PubMed.

  1. Functional precision psychiatry: iPSC-derived neurons as predictive assays for antidepressant response.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Emerging directions in tauopathy research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Temporal Transcriptional Regulation of Human Neuronal Differentiation via Forward Programming.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. HyperCas12a enables multiplexed CRISPRi screens.bioRxiv : the preprint server for biology · 2025
    Article
  18. Review
  19. Article
  20. Review

116 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jerome MertensSalk Institute for Biological Studies, Laboratory of Genetics, La Jolla, California 92037, USA.
Maria C MarchettoSalk Institute for Biological Studies, Laboratory of Genetics, La Jolla, California 92037, USA.
Cedric BardySalk Institute for Biological Studies, Laboratory of Genetics, La Jolla, California 92037, USA.
Fred H GageSalk Institute for Biological Studies, Laboratory of Genetics, La Jolla, California 92037, USA.

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
Assessing cellular aging in old and rejuvenated neurons from Alzheimer patientsR01AG056306 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI GAGE, FRED H · 2017 to 2021
$2.4M
Assessing cellular aging in old and rejuvenated neurons from Alzheimer patientsK99AG056679 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MERTENS, JEROME S. · 2017 to 2018
$201k
NCI NIH HHS P30 CA014195NIA NIH HHS K99 AG056679NIA NIH HHS R01 AG056306
6 · The paper itself

Abstract

The scarcity of live human brain cells for experimental access has for a long time limited our ability to study complex human neurological disorders and elucidate basic neuroscientific mechanisms. A decade ago, the development of methods to reprogramme somatic human cells into induced pluripotent stem cells enabled the in vitro generation of a wide range of neural cells from virtually any human individual. The growth of methods to generate more robust and defined neural cell types through reprogramming and direct conversion into induced neurons has led to the establishment of various human reprogramming-based neural disease models.

Indexed as

NeurosciencesAnimalsCell DifferentiationCellular ReprogrammingHumansInduced Pluripotent Stem CellsNeural Stem CellsNeurons

Identifiers

PMID27194476
PMCPMC6276815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.